Transoral robotic surgery (TORS) was associated with better survival and improved surgical outcomes in comparison with nonrobotic surgery in patients with early-stage oropharyngeal cancer in a retrospective analysis of nearly 10,000 cases.
The survival benefit was unexpected, note the study authors.
Recent data regarding other cancer types have led to concern that robotic surgery can be associated with worse outcomes, eg, a higher risk for death among patients with ovarian and cervical cancer.
|